💨 Abstract
Theravance Biopharma Inc. (TBPH) reported a second-quarter net income of $54.8 million, or $1.08 per share, exceeding analysts' expectations. The company's adjusted losses were 8 cents per share. Revenue reached $26.2 million, surpassing forecasts of $17 million.
Courtesy: WTOP Staff
Suggested
The group in charge of tennis in the US is starting its first coaching program -
Bills running back James Cook ends contract standoff by agreeing to four-year, $48 million deal -
Star Equity: Q2 Earnings Snapshot -
Satellos Bioscience: Q2 Earnings Snapshot -
LiveOne: Fiscal Q1 Earnings Snapshot -
Sapiens: Q2 Earnings Snapshot -
ESSA Pharma: Fiscal Q3 Earnings Snapshot -
Immatics: Q2 Earnings Snapshot -
Nayax: Q2 Earnings Snapshot -
Spanish third-tier club reverses decision to sign player after his comments anger Catalans -